Jump to content

Soquinolol

From Wikipedia, the free encyclopedia
Soquinolol
Names
IUPAC name
5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-isoquinoline-2-carbaldehyde
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.057.113 Edit this at Wikidata
UNII
  • InChI=1S/C17H26N2O3/c1-17(2,3)18-9-14(21)11-22-16-6-4-5-13-10-19(12-20)8-7-15(13)16/h4-6,12,14,18,21H,7-11H2,1-3H3
    Key: GMJHUSJLZXFFQJ-UHFFFAOYSA-N
  • InChI=1/C17H26N2O3/c1-17(2,3)18-9-14(21)11-22-16-6-4-5-13-10-19(12-20)8-7-15(13)16/h4-6,12,14,18,21H,7-11H2,1-3H3
    Key: GMJHUSJLZXFFQJ-UHFFFAOYAM
  • CC(C)(C)NCC(COC1=CC=CC2=C1CCN(C2)C=O)O
  • CC(C)(C)NCC(COc1cccc2c1CCN(C2)C=O)O
Properties
C17H26N2O3
Molar mass 306.406 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Soquinolol is a beta adrenergic receptor antagonist.[1]

References

[edit]
  1. ^ Gries, J; Unger, L; Einig, H; Friedrich, L; Hofmann, HP; Kreiskott, H; Lehmann, HD; Von Philipsborn, G; Wuppermann, D; Zimmermann, F (1988). "Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol". Arzneimittel-Forschung. 38 (9): 1271–9. PMID 2906243.